Fubei Biotech announced the completion of the Pre-B round of financing exceeding RMB 100 million
Fubei Bio is a biopharmaceutical high-tech enterprise dedicated to developing innovative drugs for neurological diseases and developing related cutting-edge technology platforms. Recently, Forbes Biotech completed the Pre-B round of financing exceeding RMB 100 million. This round of financing was led by Dachen Capital, followed by Bloomage Capital, Fangsheng Capital, Zhongguancun Collaborative Innovation Fund and Daoyuan […]